effectiveness of madanaphala vamana in tamakshwasa and comparison with Jeemutaka and Ikshwaku Vamana in Tamakshwasa

Evaluation and comparison of Madanaphala,Jeemutaka and Ikshwaku Vamana in Tamakshwas(Bronchial Asthma)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025967

Enrollment

110

Registered

2020-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: Madanaphala, Jeemutaka and Ikshwaku Vamana in tamakshwasa: 1st day sadyasnehapana dose is 48 ml Murchit ghrut next day sthanik snehana and swedana and vamana Intervention2: madanaphala

Eligibility

Inclusion criteria

Inclusion criteria: patients presenting with Tamakshwasa (Bronchial asthma)[ICD10-j45.9] Asthamatic bronchitis NOS Late-onset asthma

Exclusion criteria

Exclusion criteria: patients ages below 20 and above 50 years patients suffering from any complications or chronic illness pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Evaluation and comparison of Madanaphala,Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5 days	—

Secondary

Measure	Time frame
Ta access the Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5 days;To access the Madanaphala Vamana in TamakshwasaTimepoint: 5 days;To compare the Efficacy of Madamanaphala Vamana with Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5days;To find out the relative early clinical and biological improvement between treatment groupsTimepoint: 5days;To measure the incidence of adverse events, adverse drug reactions, safety,objective parameters(pft), lab parameters (haematology) and vital during the studyTimepoint: 5 days	—

Measure

Time frame

Ta access the Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5 days;To access the Madanaphala Vamana in TamakshwasaTimepoint: 5 days;To compare the Efficacy of Madamanaphala Vamana with Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5days;To find out the relative early clinical and biological improvement between treatment groupsTimepoint: 5days;To measure the incidence of adverse events, adverse drug reactions, safety,objective parameters(pft), lab parameters (haematology) and vital during the studyTimepoint: 5 days

—

Countries

India

Contacts

Public ContactDr kadam Sahebrao Kishanrao

Mahatma Gandhi Ayurved College, Hospital and research center Salod(H) wardha maharashtra

drshwetaparve@gmail.com9403142270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026